Right now, all the most explosive profit opportunity is concentrated in one small segment of the stock market…
These cheap stocks are not for everyone, and require a solid risk management approach. But only stocks selling for under $5/share can provide true “lotto ticket” gains – blowing Amazon, Microsoft, and even Tesla out of the water.
Dozens of tiny stocks are capitalizing on this mad rush in 2021, and already we've seen real gains of 209%… 903%… 1,434%… even 2,351% in one year…
And more than a few Mega-Gains have blown to the top of our Penny Stock Hotlist (below).
So the big question is, of course, what should a penny stock investor buy now?
The answer, for many, is still penny stocks…. and our new hotlist (below) is an excellent tool.
Related: Get in early on this $2 stock ASAP before the Robinhood traders do!
Not only is a stock trading below $5 a share much more affordable for regular investors… but cheaper stocks also tend to belong to smaller companies, who can double or triple in size much easier than a giant like Amazon.
In fact, some of the greatest companies in the world used to be tiny stocks themselves. Amazon traded for less than $2 a share in 1997. Now it's over $3,000.
Of course, with higher potential reward comes higher risk. Smaller companies and cheaper stocks means there’s more volatility and more room for bad actors to influence stock prices, so please exercise caution, and keep an eye on your trades.
These cheap stocks can go from slumber to life-changing jackpot – and sometimes back down again – in a matter of days, sometimes hours.
With that being said, below is our vetted list of the 5 best cheap stocks to buy right now:
1. Vapotherm At Long-Term Low
Vapotherm (NYSE:VAPO) is a developer of treatments for respiratory distress. The company’s primary product line is a high-flow system to deliver humidified and oxygenated air to sufferers. The company has been struggling with revenue in the wake of the pandemic, but the inside and sell-side activity suggests this company is not down for the count.
8 insiders are buying the stock including most members of the executive tea and several directors. This activity has their total holdings up to over 10% and growing, compounded by robust institutional activity. The institutions have netted $32 billion over the last year to increase their holdings to 59% of the company. Remarkably, the buying is worth more than the company’s current market cap, but that isn’t a problem for the analyst.
There are 5 analyst rating this stock and although the sentiment rating is down to a Hold from Moderate Buy last year the price target has held firm. The price target is noteworthy because it forecasts 450% upside at the consensus midpoint and more than 100% at the low end of the range. Although a tiny operator focused on devices, Vapotherm could become the target of takeover plans given the upcoming patent cliff facing most major med-tech companies today.
2. DIRRT Environmental Solutions
DIRRT Environmental Solutions (NASDAQ:DRTT) uses 3-D imaging technology to design and build custom prefabricated inserts for business, industry, and private use.
The company has seen an excellent rebound in business following the pandemic, but fears of slowing have impacted the price action. This pullback is used by 10 insiders, including major shareholders, board members, and company execs to add to their holdings.
The insiders own about 6.7% of the company, while the institutions own about 79%. The institutional activity has been flattish over the past year as have the analysts' ratings. The analyst's rating recently jumped to a Moderate Buy from a strong Hold due to an old rating falling out of the data set. The price target was also impacted but moved lower, yet still forecasts more than 100% of the upside for the market.
3. Precigen Gets Lifted By The Analysts
Precigen, Inc (NASDAQ:PGEN) is engaged in discovering and applying gene and cellular technologies.
The company has been struggling with revenue and earnings for years but recently announced a surge in licensing revenues.
This led to some optimistic analysts' activity with the stock pegged at a Buy rating with a price target more than 600% above the current price action. This news is in addition to the 5 insiders that started buying the stock in January 2023.
4. A.I. Powered Robots!
Nauticus Robotics (NASDAQ:KITT) combines two disruptive, rapidly growing trends: robotics and artificial intelligence. Moreover, the company has found a unique niche: specifically, the company has developed AI-powered robots that operate in oceans. And intriguingly, Nauticus reports that it employs many ex-NASA engineers — trailblazers — with decades of experience in researching, engineering, and building space robotics.
The company has developed “a robotic navy,” consisting of 20 pairs of robots. In April 2022, Nauticus said they would be “deployed in multiple offshore industries serving applications ranging from subsea maintenance and intervention to data collection activities.” The company explains that its robots are “controlled through acoustic communication networking and can perform a wide range of data collection, inspection, and manipulation tasks.”
Providing some validation for Nauticus, its technology, and its products, the Pentagon’s Defense Innovation Unit last year gave the company a contract to create a robot that will enable the Marines to eliminate mines from “shallow water” and develop an autonomous robot that can operate both on sea and land.
In the third quarter, the robot maker’s top line increased to $3 million, up from $2 million during the same period a year earlier.
5. Nikola: Electric Truck Company Coming after Tesla?
Nikola (NASDAQ:NKLA), an embattled electric truck maker, reported mixed fourth-quarter results on Feb. 23. But for me, the main takeaway is that the automaker remains on track to disrupt the American truck business.
On Feb. 23, the company reported that it had “successfully completed alpha pilot testing [of its fuel cell truck] with Walmart and TTSI.” The latter company is a major logistics firm. Additionally, Nikola noted that it had built 17 “beta” fuel-cell vehicles. And Nikola expects to begin delivering fuel-cell vehicles in the second half of this year.
As I’ve written previously, the evidence shows that the ability of battery-electric trucks to carry large loads over long distances is quite limited. Therefore, as American and European companies look to replace trucks powered by diesel and gasoline, I expect the demand for fuel-cell trucks powered by hydrogen to soar.
As far as battery-electric trucks are concerned, Nikola produced 133 of them and delivered 20 EVs. Last quarter, it lowered the vehicles’ charging times so that they can now be charged to 80% of their capacity in just 90 minutes.
I believe Nikola’s market capitalization of just $1.2 billion is way below its long-term outlook.
6. Tiny Biotech Wins $75 Billion Patent
There's no sector poised to deliver bigger gains in 2023 than small-cap biotech stocks.
And we found a tiny biotech firm that recently won a patent on a new treatment that has the potential to “Cut & Paste” disease from your body.
The Wall Street Journal reports this company is “transforming medicine.”
Investor's Business Daily estimates the market is worth at least $75 billion. But right now, its stock price is just a tiny fraction of that size.
This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Click here for more details on how you can profit from this unique opportunity.